Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
Compared to two months earlier, an additional 3.5 million Ohioans hunkered down in April at the height of Gov. Mike DeWine’s 40-day stay-at-home order.
Airlines want the TSA to screen passengers for a fever. It's a dicey proposition, risking travelers outrage for a procedure that experts say won't keep COVID off planes.
It should come as little surprise that the novel coronavirus outbreak has led to the disruption - to one extent or another - of countless industries. However, some may be surprised to learn that one such sector is the pharmaceutical industry and, more specifically, the global supply chain it relies on to conduct business on an ongoing basis.
Assistant Professor of Public Policy Soroush Saghafian, whose academic interests include applying operations research methods to health care management, has been working with the government of Bahrain to analyze the effectiveness of policies to address the coronavirus. Saghafian, who is a faculty affiliate of the Harvard PhD program in health policy and the Harvard Center for Health Decision Science, cautions that no one policy is best in all cases—and that governments must weigh cost and quality of life considerations. However, he says that closing businesses like cinemas and gyms for four months could be one of the most low-cost and effective measures. Saghafian shared analysis that he and his former PhD student (now an assistant professor of statistics and family medicine at Michigan State University) Alireza Boloori conducted in an HKS faculty working paper, “COVID-19: What Intervention Policies Are Most Effective? A Brief Report Using Data from Government of Bahrain.”
David Simchi-Levi, professor of engineering systems at MIT, talks about what’s next for supply chains, as the U.S. looks to reopen businesses after the coronavirus quarantine.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine